Literature DB >> 11864933

Direct thrombin inhibitors in acute coronary syndromes: present and future.

Jeffrey I Weitz1, Harry R Buller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11864933     DOI： 10.1161/hc0802.104331

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

Review 1.  Retention of atherogenic lipoproteins in atherogenesis.

Authors:  M Gustafsson; C Flood; P Jirholt; J Borén
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

Review 2.  New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Jeffrey I Weitz; John W Eikelboom; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.

Authors:  Shannon M Bates; Jeffrey I Weitz
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Long range communication between exosites 1 and 2 modulates thrombin function.

Authors:  Nicolas S Petrera; Alan R Stafford; Beverly A Leslie; Colin A Kretz; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

Review 5.  Triggers, targets and treatments for thrombosis.

Authors:  Nigel Mackman
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

Review 6.  Pharmacologic reperfusion therapy for acute myocardial infarction.

Authors:  Harry C Lowe; Briain D Mac Neill; Frans Van de Werf; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

7.  Locally activity-released bifunctional fusion protein enhances antithrombosis and alleviates bleeding risk.

Authors:  Bingxing Shi; Aiping Yu; Yuying Liu; Jingchuan Li; Jide Jin; Chunna Dong; Chutse Wu
Journal:  J Thromb Thrombolysis       Date:  2007-05-09       Impact factor: 2.300

Review 8.  Thrombin domains: structure, function and interaction with platelet receptors.

Authors:  Raimondo De Cristofaro; Erica De Candia
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

9.  A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.

Authors:  Brian L Henry; Bernhard H Monien; Paul E Bock; Umesh R Desai
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

10.  Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.

Authors:  Volker Rudolph; Tanja K Rudolph; Francisco J Schopfer; Gustavo Bonacci; Denise Lau; Katalin Szöcs; Anna Klinke; Thomas Meinertz; Bruce A Freeman; Stephan Baldus
Journal:  J Pharmacol Exp Ther       Date:  2008-08-13       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.